To determine whether YBX1 could be a novel molecular therapeutic target for tumor growth in nude mice with human lung adenocarcinoma xenografts, the lung adenocarcinoma A549 cells were injected in mice hypodermis, and the siYBX1 and the control siRNA were treated in the corresponding groups. Here, YBX1 is linked to lung adenocarcinoma.